Delivery Order SPE2DR25D3108-SPE2DR26F1PSU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,047.57 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on November 12, 2025, with completion scheduled for November 13, 2025. This competitively awarded, firm fixed-price delivery order represents a direct fulfillment of pharmaceutical needs through AmerisourceBergen's existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Jardiance 10 mg tablets (90-count) valued at $11,906.66. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The order is due for completion by November 13, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) with a firm fixed price ceiling value of $4,762.33 and completion targeted for November 26, 2025. This non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The award to AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $13,797.33. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 17, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $11,651.61 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Jardiance 10 mg tablets (90-count packages). This firm fixed-price delivery order, which is not subject to any set-aside designation, represents a competitively awarded contract under the company's existing indefinite delivery vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a $10,781.30 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price contract, with an ultimate completion date of July 25, 2025, represents a single delivery order under the company's broader pharmaceutical supply agreement. The award utilizes no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a firm fixed price ceiling value of $1,579.10. This non-set-aside, competitively awarded delivery order is scheduled for completion by November 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $15,404.48 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-competitive delivery order utilizes firm fixed pricing and is sourced from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support federal healthcare operations....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $2,056.29. This is a non-set-aside competitive award with an ultimate completion date of December 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $2,245.58 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- SPE2DR25D3108Indefinite Delivery Contract
- SPE2DR25D3108-SPE2DR26F1PSUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,895.75 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the Defense Logistics Agency's medical supply chain operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical commodities to support military and veteran healthcare systems. The company's federal contract portfolio demonstrates significant capability in delivering both brand-name and generic pharmaceutical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 11/30/25 |